Retinal Insider

High-dose Anti-VEGF in Refractory Wet AMD

Researchers say that, for certain cases, increased doses of these drugs may yield better results than a standard regimen.
07/06/2017

Retinal Prostheses¬≠— Now and in the Future

A discussion of the unique strategies used by the major retinal prostheses initiatives and their current results.
06/09/2017

Machine Learning for Diabetic Retinopathy

Adding computers to the mix may help ophthalmologists around the world catch and treat DR more effectively.
05/10/2017

OCT Technology: Will We Be “Swept” Away?

A look at the differences between spectral-domain and swept-source OCT, and the potential clinical benefits of swept-source.
04/07/2017

Combo Therapy: When One Drug’s Not Enough

A look at researchers’ attempts to gang up on wet age-related macular degeneration.
03/03/2017

A Review of Portable Retinal Imaging

A guide to using common devices such as smartphones as well as more exotic consumer-level cameras to capture images.
02/03/2017

The Clinical Utility of OCT Angiography

Retina specialists experienced in OCTA discuss the strengths—and the limitations—of this promising new technology.
01/10/2017

Ocular Vitamins: Who Benefits?

It may be possible to stretch the boundaries of the AREDS’ findings and still give patients positive results.
12/10/2016

Avoiding the Traps of Hydroxychloroquine Use

Proper communication between specialties and using the correct formula for dosing can curb toxicity.
11/05/2016

A Deeper Look at Protocols S and T

An experienced clinician and retinal researcher discusses what the trials’ findings might mean for clinical practice.
10/05/2016